Divis Laboratories (DIVISLAB.NS) Financial Analysis & Valuation | Quarter Chart

Divis Laboratories (DIVISLAB.NS)

DIVISLAB.NS
Price: $70.77
Fair Value: 🔒
🔒score
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a rang... more
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (A... more
Description Shares
Market Cap$18.79BExchangeNSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryINCEOKiran Satchandra Divi
IPO Date2003-03-12CAGR0.18%
Employees9,741Websitewww.divislabs.com
Div. Yield0.44%Payout Ratio0.31%
Buy Back Yield—Total Yield0.44%
DIVISLAB.NS chart loading...
Fundamentals Technicals
Enterprise Value$1543.53BP/E Ratio69.89
Forward P/E47.54PEG Ratio5.1
P/S Ratio16.95P/B Ratio10.67
P/CF Ratio108.74P/FCF Ratio1772.33
EPS$0.98EPS Growth 1Y17.23%
EPS Growth 3Y40.88%EPS Growth 5Y29.46%
Revenue Growth 1Y13.24%Gross Margin0.52%
Operating Margin0.28%Profit Margin0.24%
ROE0.17%ROA0.13%
ROCE0.17%Current Ratio5.43
Quick Ratio3.5Cash Ratio1.67
Debt/Equity0Interest Coverage129.48
Altman Z Score35.13Piotroski Score4

View Divis Laboratories financial charts →